4.1 Article

Hybrid In Silico Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 Variants

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Virtual screening of approved clinic drugs with main protease (3CLpro) reveals potential inhibitory effects on SARS-CoV-2

Qiang Wang et al.

Summary: Potential drugs that have high affinity with the 3CL(pro) active sites of SARS-CoV-2 have been identified through virtual screening technology and molecular dynamics simulation.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Chemistry, Medicinal

QSAR Modeling of SARS-CoV MproInhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and Other Drugs as Candidates for Repurposing against SARS-CoV-2

Vinicius M. Alves et al.

Summary: The researchers conducted virtual screening of inhibitors of the M-protease using QSAR models, and validated the effectiveness of some compounds in subsequent experiments. The results demonstrate that the models effectively guided experimental investigations of potential anti-COVID-19 drug candidates.

MOLECULAR INFORMATICS (2021)

Article Biotechnology & Applied Microbiology

Synergistic and Antagonistic Drug Combinations against SARS-CoV-2

Tesia Bobrowski et al.

Summary: This study identified 16 synergistic drug combinations against SARS-CoV-2, with nitazoxanide combined with remdesivir, amodiaquine, or umifenovir showing significant synergy. However, the combination of remdesivir with lysosomotropic drugs like hydroxychloroquine exhibited strong antagonism. The results highlight the potential of drug repurposing and preclinical testing of drug combinations for treating COVID-19.

MOLECULAR THERAPY (2021)

Article Pharmacology & Pharmacy

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2

Catherine Z. Chen et al.

Summary: Drug repurposing is a fast approach to identify therapeutics for emerging infectious diseases like COVID-19. A study identified and confirmed 319 compounds with anti-SARS-CoV-2 activities, including 230 compounds with previously unreported activities. Chlorprothixene, methotrimeprazine, and piperacetazine, three FDA-approved drugs, showed potent anti-SARS-CoV-2 activities, which were not previously reported.

FRONTIERS IN PHARMACOLOGY (2021)

Article Chemistry, Medicinal

Large-Scale Modeling of Multispecies Acute Toxicity End Points Using Consensus of Multitask Deep Learning Methods

Sankalp Jain et al.

Summary: The study reports the collection, curation, and integration of data from the ChemIDplus database for predicting toxicity using various computational modeling approaches, including deep neural networks. The developed models demonstrated significantly better performance, especially in predicting smaller tasks, and have been made publicly available to support regulatory and research applications.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Biotechnology & Applied Microbiology

Biological activity-based modeling identifies antiviral leads against SARS-CoV-2

Ruili Huang et al.

Summary: The biological activity-based modeling approach uses compound activity profiles to predict activity across different assays or targets, aiding in the discovery of potential antiviral drug candidates. This method successfully identified compounds with potential activity against Zika, Ebola, and SARS-CoV-2 viruses, demonstrating its effectiveness in predicting antiviral compounds. The confirmed anti-SARS-CoV-2 compounds show promise as potential therapies, with a focus on viral entry inhibition and autophagy modulation.

NATURE BIOTECHNOLOGY (2021)

Article Biochemical Research Methods

Validating ADME QSAR Models Using Marketed Drugs

Vishal Siramshetty et al.

Summary: Understanding the ADME properties of marketed drugs and modeling how chemical structure contributes to these inherent properties can help new projects reduce their risk profiles.

SLAS DISCOVERY (2021)

Review Chemistry, Multidisciplinary

A critical overview of computational approaches employed for COVID-19 drug discovery

Eugene N. Muratov et al.

Summary: COVID-19 has led to a large number of infections and deaths globally, causing severe disruptions to societies and economies. Extensive experimental and computational research efforts have been made to quickly develop diagnostics, vaccines, and drugs to combat the pandemic. Although drug repurposing has not provided rapid and global solutions, known drugs have been used in clinical settings and new clinical candidates are being considered in trials. Truly impactful computational tools that provide testable hypotheses and rapid sharing of research results are crucial for the development of much-needed therapeutics for COVID-19.

CHEMICAL SOCIETY REVIEWS (2021)

Article Biochemistry & Molecular Biology

Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises

Natesh Singh et al.

Summary: New therapies are urgently needed to prevent SARS-CoV-2 infection and improve outcomes for COVID-19 patients. While several vaccines have been developed, there is ongoing research on other types of therapeutic agents. This article introduces databases and online tools for discovering anti-SARS-CoV-2 compounds and highlights the lack of discussion and planning in academic research during the crisis.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Chemistry, Medicinal

A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors

Serena Vittorio et al.

MOLECULAR INFORMATICS (2020)

Article Medicine, Research & Experimental

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

Abdo A. Elfiky

LIFE SCIENCES (2020)

Article Mathematical & Computational Biology

Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov

Haiping Zhang et al.

INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2020)

Article Chemistry, Medicinal

Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19

Sirle Saul et al.

ACS INFECTIOUS DISEASES (2020)

Article Chemistry, Medicinal

Systemic In Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server

Chi Xu et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Article Chemistry, Medicinal

The SARS-CoV-2 main protease as drug target

Sven Ullrich et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Article Multidisciplinary Sciences

Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models

Vishal B. Siramshetty et al.

SCIENTIFIC REPORTS (2020)

Article Chemistry, Medicinal

Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening

Wei Zhu et al.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

Article Biochemistry & Molecular Biology

Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity

Hongmao Sun et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2019)

Article Mathematical & Computational Biology

Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands

Mubarak A. Alamri et al.

BIOINFORMATION (2019)

Article Biochemistry & Molecular Biology

Comparing the performance of meta-classifiers-a case study on selected imbalanced data sets relevant for prediction of liver toxicity

Sankalp Jain et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2018)

Article Chemistry, Medicinal

Classifiers and their Metrics Quantified

J. B. Brown

MOLECULAR INFORMATICS (2018)

Article Chemistry, Medicinal

Benchmarking Commercial Conformer Ensemble Generators

Nils-Ole Friedrich et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)

Article Biochemistry & Molecular Biology

Structure based classification for bile salt export pump (BSEP) inhibitors using comparative structural modeling of human BSEP

Sankalp Jain et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2017)

Article Biochemistry & Molecular Biology

Highly predictive and interpretable models for PAMPA permeability

Hongmao Sun et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation

Denis Fourches et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)

Article Medicine, Research & Experimental

QSAR Modeling and Prediction of Drug-Drug Interactions

Alexey V. Zakharov et al.

MOLECULAR PHARMACEUTICS (2016)

Letter Biochemistry & Molecular Biology

Curation of chemogenomics data

Denis Fourches et al.

NATURE CHEMICAL BIOLOGY (2015)

Article Chemistry, Medicinal

Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research

Denis Fourches et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)

Article Biochemistry & Molecular Biology

Efficient overlay of small organic molecules using 3D pharmacophores

Gerhard Wolber et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)

Article Multidisciplinary Sciences

Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries

James Inglese et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Biochemistry & Molecular Biology

Virtual screening in lead discovery: A viewpoint

TL Oprea

MOLECULES (2002)

Article Computer Science, Artificial Intelligence

Random forests

L Breiman

MACHINE LEARNING (2001)